Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.

Bibliographic Details
Title: Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
Authors: Lauring, Adam S., Tenforde, Mark W., Chappell, James D., Gaglani, Manjusha, Ginde, Adit A., McNeal, Tresa, Ghamande, Shekhar, Douin, David J., Talbot, H. Keipp, Casey, Jonathan D., Mohr, Nicholas M., Zepeski, Anne, Shapiro, Nathan I., Gibbs, Kevin W., Files, D. Clark, Hager, David N., Shehu, Arber, Prekker, Matthew E., Erickson, Heidi L., Exline, Matthew C.
Source: BMJ: British Medical Journal; 3/19/2022, Vol. 376 Issue 8330, p1-12, 12p
Subject Terms: HOSPITALS, DISEASE progression, GENETIC mutation, SEQUENCE analysis, SCIENTIFIC observation, CONFIDENCE intervals, COVID-19 vaccines, PATIENTS, CASE-control method, HEALTH outcome assessment, DISEASES, TREATMENT effectiveness, SEVERITY of illness index, HOSPITAL admission & discharge, MESSENGER RNA, ODDS ratio, PROPORTIONAL hazards models, LONGITUDINAL method
Geographic Terms: UNITED States
Database: Complementary Index
More Details
ISSN:17561833
DOI:10.1136/bmj-2021-069761
Published in:BMJ: British Medical Journal
Language:English